Back to Journals » Biologics: Targets and Therapy » Volume 5 » default

Biologics: Targets and Therapy

ISSN: 1177-5491


Archive: Volume 5, 2011

Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions

Almer G, Saba-Lepek M, Haj-Yahya S, Rohde E, Strunk D, Fröhlich E, Prassl R, Mangge H

Biologics: Targets and Therapy 2011, 5:95-105

Published Date: 7 September 2011

Current neoadjuvant treatment options for HER2 positive breast cancer

Abdel-Razeq H, Marei L

Biologics: Targets and Therapy 2011, 5:87-94

Published Date: 9 August 2011

Gut microbiota: next frontier in understanding human health and development of biotherapeutics

Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C

Biologics: Targets and Therapy 2011, 5:71-86

Published Date: 11 July 2011

The role of stem cells in tumor targeting and growth suppression of gliomas

Eskandary H, Basiri M, Nematollahi-Mahani SN, Mehravaran S

Biologics: Targets and Therapy 2011, 5:61-70

Published Date: 5 April 2011

A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex

Stephen P Myers, Joan O'Connor, J Helen Fitton, et al

Biologics: Targets and Therapy 2011, 5:45-60

Published Date: 15 February 2011

An update on belimumab for the treatment of lupus

Aikaterini Thanou-Stavraki, Amr H Sawalha,

Biologics: Targets and Therapy 2011, 5:33-43

Published Date: 14 February 2011

Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress

Bibiana Garcia-Bailo, Ahmed El-Sohemy, Pierre S Haddad, et al

Biologics: Targets and Therapy 2011, 5:7-19

Published Date: 19 January 2011

Bevacizumab in the treatment of ovarian cancer

Ramez N Eskander, Leslie M Randall

Biologics: Targets and Therapy 2011, 5:1-5

Published Date: 11 January 2011